Strata Critical Medical, Inc. Quarterly report pursuant to Section 13 or 15(d)

Intangible Assets (Tables)

3 Months Ended

Mar. 31, 2022

The following table presents information about the Company's intangible assets as of:


		March 31, 2022						December 31, 2021
	Estimated Useful Life	Gross Carrying Amount		Accumulated Amortization		Net		Gross Carrying Amount		Accumulated Amortization		Net
Exclusive rights to Helijet’s scheduled passenger routes in Canada	5 years	$	12,617	$	(841)	$	11,776	$	12,357	$	(206)	$	12,151
Customer list	5-10 years	11,542		(1,270)		10,272		11,542		(957)		10,585
Domain name	Indefinite	504		—		504		504		—		504
Trademarks	6-10 years	1,006		(93)		913		1,006		(51)		955
Developed technology	3 years	250		(45)		205		250		(24)		226
Total		$	25,919	$	(2,249)	$	23,670	$	25,659	$	(1,238)	$	24,421

The following table presents information about the Company's intangible assets as of:


		March 31, 2022						December 31, 2021
	Estimated Useful Life	Gross Carrying Amount		Accumulated Amortization		Net		Gross Carrying Amount		Accumulated Amortization		Net
Exclusive rights to Helijet’s scheduled passenger routes in Canada	5 years	$	12,617	$	(841)	$	11,776	$	12,357	$	(206)	$	12,151
Customer list	5-10 years	11,542		(1,270)		10,272		11,542		(957)		10,585
Domain name	Indefinite	504		—		504		504		—		504
Trademarks	6-10 years	1,006		(93)		913		1,006		(51)		955
Developed technology	3 years	250		(45)		205		250		(24)		226
Total		$	25,919	$	(2,249)	$	23,670	$	25,659	$	(1,238)	$	24,421

As of March 31, 2022, the estimated amortization expense of its finite-lived intangible assets for each of the next five years are as follows: